Cara Therapeutics (CARA) Revenue & Revenue Breakdown
Cara Therapeutics Revenue Highlights
Latest Revenue (Y)
$20.97M
Latest Revenue (Q)
$991.00K
Main Segment (Y)
Other Revenue
Cara Therapeutics Revenue by Period
Cara Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $20.97M | -49.92% |
| 2022-12-31 | $41.87M | 81.81% |
| 2021-12-31 | $23.03M | -82.95% |
| 2020-12-31 | $135.08M | 579.28% |
| 2019-12-31 | $19.89M | 47.64% |
| 2018-12-31 | $13.47M | 1378.49% |
| 2017-12-31 | $911.00K | 959.30% |
| 2016-12-31 | $86.00K | -97.74% |
| 2015-12-31 | $3.80M | 19.70% |
| 2014-12-31 | $3.18M | -73.45% |
| 2013-12-31 | $11.96M | 905.38% |
| 2012-12-31 | $1.19M | 100.00% |
| 2011-12-31 | - | - |
Cara Therapeutics generated $20.97M in revenue during NA 2023, up -49.92% compared to the previous quarter, and up 155.68% compared to the same period a year ago.
Cara Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $991.00K | -53.58% |
| 2024-03-31 | $2.13M | -28.93% |
| 2023-12-31 | $3.00M | -38.27% |
| 2023-09-30 | $4.87M | -29.81% |
| 2023-06-30 | $6.93M | 12.46% |
| 2023-03-31 | $6.17M | 89.05% |
| 2022-12-31 | $3.26M | -69.84% |
| 2022-09-30 | $10.81M | -52.99% |
| 2022-06-30 | $23.00M | 380.23% |
| 2022-03-31 | $4.79M | 483.43% |
| 2021-12-31 | $821.00K | -95.95% |
| 2021-09-30 | $20.27M | 100.00% |
| 2021-06-30 | - | -100.00% |
| 2021-03-31 | $1.94M | -98.27% |
| 2020-12-31 | $112.09M | 1109.68% |
| 2020-09-30 | $9.27M | 64.47% |
| 2020-06-30 | $5.63M | -30.38% |
| 2020-03-31 | $8.09M | 79.41% |
| 2019-12-31 | $4.51M | -22.02% |
| 2019-09-30 | $5.79M | 11.08% |
| 2019-06-30 | $5.21M | 18.85% |
| 2019-03-31 | $4.38M | -20.80% |
| 2018-12-31 | $5.53M | 9.30% |
| 2018-09-30 | $5.06M | 76.13% |
| 2018-06-30 | $2.87M | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | -100.00% |
| 2017-03-31 | $911.00K | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | -100.00% |
| 2016-06-30 | $79.00K | 1028.57% |
| 2016-03-31 | $7.00K | 100.00% |
| 2015-12-31 | - | -100.00% |
| 2015-09-30 | $2.44M | 179.18% |
| 2015-06-30 | $874.00K | 78.73% |
| 2015-03-31 | $489.00K | -46.50% |
| 2014-12-31 | $914.00K | -18.76% |
| 2014-09-30 | $1.13M | 17.19% |
| 2014-06-30 | $960.00K | 439.33% |
| 2014-03-31 | $178.00K | -81.71% |
| 2013-12-31 | $973.00K | -4.42% |
| 2013-09-30 | $1.02M | -89.79% |
| 2013-06-30 | $9.97M | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | - |
Cara Therapeutics generated $991.00K in revenue during Q2 2024, up -53.58% compared to the previous quarter, and up 16.07% compared to the same period a year ago.
Cara Therapeutics Revenue Breakdown
Cara Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 18 |
|---|---|---|
| Other Revenue | $699.00K | - |
| License And Milestone Fees | - | $13.44M |
Cara Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Other Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 22 | Mar 22 |
|---|---|---|---|---|
| Collaborative revenue | $788.00K | $788.00K | - | - |
| Commercial supply revenue | $640.00K | $640.00K | - | - |
| Other Revenue | $991.00K | $623.00K | - | - |
| Commercial Supply Revenue | - | - | $2.06M | $4.79M |
| Commercial Supply Revenue With Associated Costs Of Goods Sold | - | - | - | $2.50M |
Cara Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Other Revenue (40.97%), Collaborative revenue (32.58%), and Commercial supply revenue (26.46%).
Cara Therapeutics Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Dec 22 | Mar 22 |
|---|---|---|
| Commercial Supply Revenue | $2.06M | $4.79M |
| Commercial Supply Revenue With Associated Costs Of Goods Sold | - | $2.50M |
Cara Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 22: Commercial Supply Revenue (100.00%).
CARA Revenue FAQ
What is Cara Therapeutics’s yearly revenue?
Cara Therapeutics's yearly revenue for 2023 was $20.97M, representing a decrease of -49.92% compared to 2022. The company's yearly revenue for 2022 was $41.87M, representing an increase of 81.81% compared to 2021. CARA's yearly revenue for 2021 was $23.03M, representing a decrease of -82.95% compared to 2020.
What is Cara Therapeutics’s quarterly revenue?
Cara Therapeutics's quarterly revenue for Q2 2024 was $991K, a -53.58% decrease from the previous quarter (Q1 2024), and a -85.71% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2.14M, a -28.93% decrease from the previous quarter (Q4 2023), and a -65.37% decrease year-over-year (Q1 2023). CARA's quarterly revenue for Q4 2023 was $3M, a -38.27% decrease from the previous quarter (Q3 2023), and a -7.88% decrease year-over-year (Q4 2022).
What is Cara Therapeutics’s revenue growth rate?
Cara Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -8.95%, and for the last 5 years (2019-2023) was 5.44%.
What are Cara Therapeutics’s revenue streams?
Cara Therapeutics's revenue streams in c 23 are Other Revenue
What is Cara Therapeutics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Cara Therapeutics was Other Revenue. This segment made a revenue of $699K, representing 100.00% of the company's total revenue.